George Christopher Eliades

Insider Reports History

Entity
Individual
Location
C/O Oyster Point Pharma, Inc., 202 Carnegie Center, Suite 109, Princeton, New Jersey
Signature
/s/ Brandon Fenn, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by George Christopher Eliades:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oyster Point Pharma, Inc. Director Common Stock 0 $11.20 Jan 3, 2023 Direct
Oyster Point Pharma, Inc. Director Stock Option (Right to Buy) 0 Jan 3, 2023 Direct

Insider Reports Filed by George Christopher Eliades

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OYST Oyster Point Pharma, Inc. Jan 3, 2023 4 $0 4 Jan 4, 2023 Director
OYST Oyster Point Pharma, Inc. Jun 6, 2022 2 $0 4 Jun 8, 2022 Director
OYST Oyster Point Pharma, Inc. Jun 7, 2021 2 $0 4 Jun 9, 2021 Director